Literature DB >> 30923396

The Newly Available FAERS Public Dashboard: Implications for Health Care Professionals.

Atul Kumar1.   

Abstract

Year:  2018        PMID： 30923396      PMCID： PMC6431724          DOI： 10.1177/0018578718795271

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


× No keyword cloud information.
  2 in total

1.  Teaching the science of safety in US colleges and schools of pharmacy.

Authors:  David A Holdford; Terri L Warholak; Donna West-Strum; John P Bentley; Daniel C Malone; John E Murphy
Journal:  Am J Pharm Educ       Date:  2011-05-10       Impact factor: 2.047

Review 2.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228
  2 in total
  8 in total

1.  Medications mostly associated with priapism events: assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database entries.

Authors:  Nicolò Schifano; Paolo Capogrosso; Luca Boeri; Giuseppe Fallara; Omer Onur Cakir; Fabio Castiglione; Hussain M Alnajjar; Asif Muneer; Federico Deho'; Fabrizio Schifano; Francesco Montorsi; Andrea Salonia
Journal:  Int J Impot Res       Date:  2022-05-21       Impact factor: 2.896

2.  Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases.

Authors:  Nicolò Schifano; Paolo Capogrosso; Luca Boeri; Giuseppe Fallara; Stefania Chiappini; Matthew Rewhorn; Omer Onur Cakir; Hannah Harvey; Fabio Castiglione; Hussain M Alnajjar; Asif Muneer; Federico Deho'; Fabrizio Schifano; Francesco Montorsi; Andrea Salonia
Journal:  Int J Impot Res       Date:  2022-05-05       Impact factor: 2.896

3.  Extraction of Information Related to Adverse Drug Events from Electronic Health Record Notes: Design of an End-to-End Model Based on Deep Learning.

Authors:  Fei Li; Weisong Liu; Hong Yu
Journal:  JMIR Med Inform       Date:  2018-11-26

4.  Adverse Events Due to Insomnia Drugs Reported in a Regulatory Database and Online Patient Reviews: Comparative Study.

Authors:  Jill S Borchert; Bo Wang; Muzaina Ramzanali; Amy B Stein; Latha M Malaiyandi; Kirk E Dineley
Journal:  J Med Internet Res       Date:  2019-11-08       Impact factor: 5.428

5.  The risk of pulmonary adverse drug reactions of rebamipide and other drugs for acid-related diseases: An analysis of the national pharmacovigilance database in South Korea.

Authors:  Bo Ram Yang; Jae-Young Lee; Myeong Gyu Kim
Journal:  J Dig Dis       Date:  2022-02-09       Impact factor: 3.366

6.  Prediction of Alternative Drug-Induced Liver Injury Classifications Using Molecular Descriptors, Gene Expression Perturbation, and Toxicology Reports.

Authors:  Wojciech Lesiński; Krzysztof Mnich; Witold R Rudnicki
Journal:  Front Genet       Date:  2021-07-01       Impact factor: 4.599

7.  Broad-Spectrum Profiling of Drug Safety via Learning Complex Network.

Authors:  Ke Liu; Ruo-Fan Ding; Han Xu; Yang-Mei Qin; Qiu-Shun He; Fei Du; Yun Zhang; Li-Xia Yao; Pan You; Yan-Ping Xiang; Zhi-Liang Ji
Journal:  Clin Pharmacol Ther       Date:  2020-02-28       Impact factor: 6.875

8.  Open Targets Platform: supporting systematic drug-target identification and prioritisation.

Authors:  David Ochoa; Andrew Hercules; Miguel Carmona; Daniel Suveges; Asier Gonzalez-Uriarte; Cinzia Malangone; Alfredo Miranda; Luca Fumis; Denise Carvalho-Silva; Michaela Spitzer; Jarrod Baker; Javier Ferrer; Arwa Raies; Olesya Razuvayevskaya; Adam Faulconbridge; Eirini Petsalaki; Prudence Mutowo; Sandra Machlitt-Northen; Gareth Peat; Elaine McAuley; Chuang Kee Ong; Edward Mountjoy; Maya Ghoussaini; Andrea Pierleoni; Eliseo Papa; Miguel Pignatelli; Gautier Koscielny; Mohd Karim; Jeremy Schwartzentruber; David G Hulcoop; Ian Dunham; Ellen M McDonagh
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.